Published in Leuk Res on August 21, 1992
Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol Rev (1995) 1.32
Interleukin-15 augments superoxide production and microbicidal activity of human monocytes against Candida albicans. Infect Immun (1998) 0.98
Blood monocytes of untreated asthmatics exhibit some features of tissue macrophages. Clin Exp Immunol (1995) 0.94
Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science (1999) 8.43
Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest (2000) 3.78
Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts. J Exp Med (1977) 3.48
Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplant (2008) 2.10
Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity. Leukemia (2006) 2.04
Spontaneous murine B-cell leukaemia. Nature (1978) 1.88
Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon,delta proteins. J Exp Med (1992) 1.81
Molecular diagnosis of cat scratch disease: a two-step approach. J Clin Microbiol (1997) 1.76
Guidelines for the retention, storage, and use of residual dried blood spot samples after newborn screening analysis: statement of the Council of Regional Networks for Genetic Services. Biochem Mol Med (1996) 1.72
Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome. Bone Marrow Transplant (2006) 1.67
Long-term survival of skin allografts in mice treated with fractionated total lymphoid irradiation. Science (1976) 1.66
Congenital corneal clouding with abnormal systemic storage bodies: a new variant of mucolipidosis. J Pediatr (1974) 1.64
Rapid and efficient homing of human CD34(+)CD38(-/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice. Blood (2001) 1.62
Safety of retroviral gene marking with a truncated NGF receptor. Nat Med (2003) 1.60
Treatment of post-hematopoietic stem cell transplantation hemorrhagic cystitis with intravesicular sodium hyaluronate. Bone Marrow Transplant (2006) 1.57
Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies. Leukemia (2007) 1.54
Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells. Leukemia (2006) 1.50
Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide. Ann Neurol (1993) 1.48
Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myeloma. Leukemia (2004) 1.45
Postpartum umbilical cord blood collection for transplantation: a comparison of three methods. Am J Obstet Gynecol (2000) 1.45
Fractionated total lymphoid irradiation as preparative immunosuppression in high risk renal transplantation: clinical and immunological studies. Ann Surg (1982) 1.44
Transplantation tolerance in adult rats using total lymphoid irradiation: permanent survival of skin, heart, and marrow allografts. J Exp Med (1978) 1.44
Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta). Proc Natl Acad Sci U S A (1999) 1.42
Low molecular weight heparin for Hickman catheter--induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation. Cancer (1992) 1.42
Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation. J Exp Med (1978) 1.40
B-cell non-Hodgkin's lymphoma: evidence for the t (14;18) translocation in all hematopoietic cell lineages. J Natl Cancer Inst (1996) 1.39
Fludarabine-based protocol for human umbilical cord blood transplantation in children with Fanconi anemia. J Pediatr Hematol Oncol (1999) 1.39
The presence of two different infantile Tay-Sachs disease mutations in a Cajun population. Am J Hum Genet (1992) 1.39
Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma. J Immunother (2001) 1.38
Seroconversion in context. AIDS Care (2003) 1.38
Characterization of a spontaneous murine B cell leukemia (BCL1). I. Cell surface expression of IgM, IgD, Ia, and FcR. J Immunol (1979) 1.33
Immunobiology of a spontaneous murine B cell leukemia (BCL1). Immunol Rev (1979) 1.31
The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD. Tissue Antigens (2004) 1.31
Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (1998) 1.30
Antibodies to papain. A selective fractionation according to inhibitory capacity. Biochemistry (1967) 1.30
Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma. Bone Marrow Transplant (2006) 1.29
Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements. Proc Natl Acad Sci U S A (2003) 1.26
Further purification of the mitochondrial inner membrane autoantigen reacting with primary biliary cirrhosis sera. Immunology (1974) 1.26
Cat-scratch disease osteomyelitis from a dog scratch. J Bone Joint Surg Br (1998) 1.24
Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis. Clin Exp Allergy (2002) 1.23
Bone marrow-derived stromal cell line expressing osteoblastic phenotype in vitro and osteogenic capacity in vivo. J Cell Physiol (1989) 1.23
Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study. Leukemia (2007) 1.22
Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity (2006) 1.22
Right atrial thrombi are related to indwelling central venous catheter position: insights into time course and possible mechanism of formation. Am Heart J (1998) 1.21
Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody. Proc Natl Acad Sci U S A (2000) 1.20
Epidemiology of rob beta-lactamase among ampicillin-resistant Haemophilus influenzae isolates in the United States. J Infect Dis (1988) 1.19
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood (2000) 1.19
Halofuginone: a potent inhibitor of critical steps in angiogenesis progression. FASEB J (2000) 1.18
Use of total lymphoid irradiation in tissue transplantation in mice. Transplant Proc (1977) 1.18
Characterization of the spontaneous murine B cell leukemia (BCL1). III. Evidence for monoclonality by using an anti-idiotype antibody. J Immunol (1979) 1.18
Halofuginone: a novel antifibrotic therapy. Gen Pharmacol (1998) 1.18
Isolation and characterization of target sequences of the chicken CdxA homeobox gene. Nucleic Acids Res (1993) 1.17
Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant (1993) 1.17
Transplantation tolerance after total lymphoid irradiation. Transplant Proc (1979) 1.15
Impaired monocyte function in liver cirrhosis. Br Med J (Clin Res Ed) (1981) 1.13
Understanding Concerns About Treatment-as-Prevention Among People with HIV who are not Using Antiretroviral Therapy. AIDS Behav (2015) 1.13
Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era? Ann Oncol (2005) 1.12
Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation. Bone Marrow Transplant (2001) 1.11
Differences between graft product and donor side effects following bone marrow or stem cell donation. Bone Marrow Transplant (2003) 1.11
Granuloma formation in cryptococcosis. Isr J Med Sci (1970) 1.10
Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine. Cytotherapy (2004) 1.10
Gene expression during chemically induced liver fibrosis: effect of halofuginone on TGF-beta signaling. Cell Tissue Res (2006) 1.10
Doctoring: University of California, Los Angeles. Acad Med (1998) 1.09
Massive pericardial effusion complicating the course of chronic graft-versus-host disease (cGVHD) in a child with acute lymphoblastic leukemia following allogeneic bone marrow transplantation. Bone Marrow Transplant (1997) 1.09
Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma. Leukemia (2008) 1.08
Total lymphoid irradiation prevents diabetes mellitus in the Bio-Breeding/Worcester (BB/W) rat. Diabetes (1984) 1.08
Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: long-term follow-up. Leukemia (2010) 1.08
Allograft tolerance after total lymphoid irradiation (TLI). Immunol Rev (1979) 1.07
Enzyme immunoassay for the diagnosis of cat-scratch disease defined by polymerase chain reaction. Clin Infect Dis (2001) 1.07
Halofuginone, a specific inhibitor of collagen type I synthesis, prevents dimethylnitrosamine-induced liver cirrhosis. J Hepatol (1997) 1.07
High-throughput, sensitive and quantitative assay for the detection of BCR-ABL kinase domain mutations. Leukemia (2007) 1.06
Long-term outcome in treated combined methylmalonic acidemia and homocystinemia. Genet Med (2001) 1.05
Aspergillus quadrilineatus, a new causative agent of fungal sinusitis. J Clin Microbiol (1992) 1.05
Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats. Hepatology (2001) 1.05
Soluble tumor necrosis factor (sTNF) receptors: a possible prognostic marker for bone marrow transplantation-related complications. Cytokines Mol Ther (1996) 1.02
Functional clonal deletion versus active suppression in transplantation tolerance induced by total-lymphoid irradiation. Transplantation (1985) 1.02
Inhibition of neovascularization and tumor growth, and facilitation of wound repair, by halofuginone, an inhibitor of collagen type I synthesis. Neoplasia (1999) 1.02
Mini-allografts: ongoing trials in humans. Bone Marrow Transplant (2000) 1.02
Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias. Leukemia (2003) 1.01
Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide). Proc Natl Acad Sci U S A (1993) 1.00
Amelioration of diabetes in nonobese diabetic mice with advanced disease by linomide-induced immunoregulation combined with Reg protein treatment. Endocrinology (1998) 1.00
Halofuginone inhibits NF-kappaB and p38 MAPK in activated T cells. J Leukoc Biol (2006) 1.00
Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation. Hepatology (1993) 0.99
Alloantigen persistence in induction and maintenance of transplantation tolerance. J Exp Med (1987) 0.99
Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS). Bone Marrow Transplant (2006) 0.99
Health care reform as perceived by first year medical students. J Community Health (1994) 0.99
Cytokine dysregulation in chronic graft versus host disease. Leuk Lymphoma (1995) 0.99
Osmotic behavior of normal and leukemic lymphocytes. Blood (1975) 0.98